Unknown

Dataset Information

0

Activity-dependent targeting of TRPV1 with a pore-permeating capsaicin analog.


ABSTRACT: The capsaicin receptor TRPV1 is the principal transduction channel for nociception. Excessive TRPV1 activation causes pathological pain. Ideal pain mangement requires selective inhibition of hyperactive pain-sensing neurons, but sparing normal nociception. We sought to determine whether it is possible to use activity-dependent TRPV1 agonists to identify nerves with excessive TRPV1 activity, as well as exploit the TRPV1 pore to deliver charged anesthetics for neuronal silencing. We synthesized a series of permanently charged capsaicinoids and found that one, cap-ET, efficaciously evoked TRPV1-dependent entry of Ca(2+) or the large cationic dye YO-PRO-1 comparably to capsaicin, but far smaller electrical currents. Cap-ET-induced YO-PRO-1 transport required permeation of both the agonist and the dye through the TRPV1 pore and could be enhanced by kinase activation or oxidative covalent modification. Moreover, cap-ET reduced capsaicin-induced currents by a voltage-dependent block of the pore. A low dose of cap-ET elicited entry of permanently charged Na(+) channel blockers to effectively suppress Na(+) currents in sensory neurons presensitized with oxidative chemicals. These results implicate therapeutic potential of these unique TRPV1 agonists exhibiting activity-dependent ion transport but of minimal pain-producing risks.

SUBMITTER: Li H 

PROVIDER: S-EPMC3100990 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Activity-dependent targeting of TRPV1 with a pore-permeating capsaicin analog.

Li Hui H   Wang Shu S   Chuang Alexander Y AY   Cohen Bruce E BE   Chuang Huai-Hu HH  

Proceedings of the National Academy of Sciences of the United States of America 20110502 20


The capsaicin receptor TRPV1 is the principal transduction channel for nociception. Excessive TRPV1 activation causes pathological pain. Ideal pain mangement requires selective inhibition of hyperactive pain-sensing neurons, but sparing normal nociception. We sought to determine whether it is possible to use activity-dependent TRPV1 agonists to identify nerves with excessive TRPV1 activity, as well as exploit the TRPV1 pore to deliver charged anesthetics for neuronal silencing. We synthesized a  ...[more]

Similar Datasets

| S-EPMC6294906 | biostudies-literature
| S-EPMC2905675 | biostudies-literature
| S-EPMC9421981 | biostudies-literature
| S-EPMC8335751 | biostudies-literature
| S-EPMC8742357 | biostudies-literature
| S-EPMC6592244 | biostudies-literature
| S-EPMC4738735 | biostudies-literature
| S-EPMC2217413 | biostudies-literature
| S-EPMC10077575 | biostudies-literature
| S-EPMC4945767 | biostudies-literature